DNA-binding regulates site-specific ubiquitination of IRF-1

Biochemical Journal

Volumn 449, Issue 3, 2013, Pages 707-717

  Landré, Vivien ^a   Pion, Emmanuelle ^a,b   Narayan, Vikram ^a   Xirodimas, Dimitris P ^b   Ball, Kathryn L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CNRS   (France)

Author keywords

C terminus of the heat shock cognate 70 interacting protein (CHIP); DNA binding; Interferon regulatory factor 1 (IRF 1); Murine double minute 2 (MDM2); Transcription; Ubiquitination

Indexed keywords

HEAT SHOCK COGNATE PROTEIN 70; INTERFERON REGULATORY FACTOR 1; LYSINE; PROTEIN MDM2; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA CONFORMATION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; REGULATORY MECHANISM; UBIQUITINATION;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE; DNA; HUMANS; INTERFERON REGULATORY FACTOR-1; LYSINE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

MURINAE; RUMEX;

EID: 84872460484     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121076     Document Type: Article

References (43)

1. Pickart, C. M. and Eddins, M. J. (2004) Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 1695, 55-72 (Pubitemid 39585154)
2. Komander, D. and Rape, M. (2012) The ubiquitin code. Annu. Rev. Biochem. 81, 203-229
3. Metzger, M. B. and Weissman, A. M. (2010) Working on a chain: E3s ganging up for ubiquitylation. Nat. Cell Biol. 12, 1124-1126
4. Kim, H. T., Kim, K. P., Lledias, F., Kisselev, A. F., Scaglione, K. M., Skowyra, D., Gygi, S. P. and Goldberg, A. L. (2007) Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 282, 17375-17386 (Pubitemid 47100279)
5. Wickliffe, K. E., Williamson, A., Meyer, H. J., Kelly, A. and Rape, M. (2011) K11-linked ubiquitin chains as novel regulators of cell division. Trends Cell Biol. 21, 656-663
6. Catic, A., Collins, C., Church, G. M. and Ploegh, H. L. (2004) Preferred in vivo ubiquitination sites. Bioinformatics 20, 3302-3307 (Pubitemid 40136763)
7. Liebermann, D. A. and Hoffman, B. (2009) Good and bad IRF-1: role in tumor suppression versus autoimmune disease. Leuk. Res. 33, 1301-1302
8. Ren, Z., Wang, Y., Tao, D., Liebenson, D., Liggett, T., Goswami, R., Clarke, R., Stefoski, D. and Balabanov, R. (2011) Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis. J. Neurosci. 31, 8329-8341
9. Willman, C. L., Sever, C. E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M. L., Yamamoto, H., Harada, K., Meeker, T. C., List, A. F. et al. (1993) Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259, 968-971 (Pubitemid 23080665)
10. Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y., Terashima, M., Saito, K. and Satodate, R. (1996) Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 56, 612-615 (Pubitemid 26043662)
11. Green, W. B., Slovak, M. L., Chen, I. M., Pallavicini, M., Hecht, J. L. and Willman, C. L. (1999) Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31). Leukemia 13, 1960-1971
12. Wang, Y., Liu, D. P., Chen, P. P., Koeffler, H. P., Tong, X. J. and Xie, D. (2007) Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res. 67, 2535-2543 (Pubitemid 46548938)
13. Pion, E., Narayan, V., Eckert, M. and Ball, K. L. (2009) Role of the IRF-1 enhancer domain in signalling polyubiquitination and degradation. Cell. Signalling 21, 1479-1487
14. Nakagawa, K. and Yokosawa, H. (2000) Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability. Eur. J. Biochem. 267, 1680-1686 (Pubitemid 30165521)
15. Narayan, V., Pion, E., Landre, V., Muller, P. and Ball, K. L. (2011) Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP. J. Biol. Chem. 286, 607-619
16. Narayan, V., Halada, P., Hernychova, L., Chong, Y. P., Zakova, J., Hupp, T. R., Vojtesek, B. and Ball, K. L. (2011) A multiprotein binding interface in an intrinsically disordered region of the tumor suppressor protein interferon regulatory factor-1. J. Biol. Chem. 286, 14291-14303
17. Pamment, J., Ramsay, E., Kelleher, M., Dornan, D. and Ball, K. L. (2002) Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 21, 7776-7785 (Pubitemid 35398835)
18. Beresford, P. J., Zhang, D., Oh, D. Y., Fan, Z., Greer, E. L., Russo, M. L., Jaju, M. and Lieberman, J. (2001) Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J. Biol. Chem. 276, 43285-43293
19. Ivanov, A. V., Peng, H., Yurchenko, V., Yap, K. L., Negorev, D. G., Schultz, D. C., Psulkowski, E., Fredericks, W. J., White, D. E., Maul, G. G. et al. (2007) PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol. Cell 28, 823-837 (Pubitemid 350217061)
20. Wallace, M., Worrall, E., Pettersson, S., Hupp, T. R. and Ball, K. L. (2006) Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol. Cell 23, 251-263 (Pubitemid 44062366)
21. Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E. L. and Taniguchi, T. (1989) Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 337, 270-272 (Pubitemid 19030564)
22. Ruiz-Ruiz, C., Ruiz de Almodovar, C., Rodriguez, A., Ortiz-Ferron, G., Redondo, J. M. and Lopez-Rivas, A. (2004) The up-regulation of human caspase-8 by interferon-γ in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J. Biol. Chem. 279, 19712-19720 (Pubitemid 38623409)
23. Lace, M. J., Anson, J. R., Klingelhutz, A. J., Harada, H., Taniguchi, T., Bossler, A. D., Haugen, T. H. and Turek, L. P. (2009) Interferon-β treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis 30, 1336-1344
24. Gongora, C., Degols, G., Espert, L., Hua, T. D. and Mechti, N. (2000) A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res. 28, 2333-2341 (Pubitemid 30349038)
25. Clarke, N., Jimenez-Lara, A. M., Voltz, E. and Gronemeyer, H. (2004) Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J. 23, 3051-3060 (Pubitemid 39093599)
26. Walerych, D., Kudla, G., Gutkowska, M., Wawrzynow, B., Muller, L., King, F. W., Helwak, A., Boros, J., Zylicz, A. and Zylicz, M. (2004) Hsp90 chaperones wild-type p53 tumor suppressor protein. J. Biol. Chem. 279, 48836-48845 (Pubitemid 39625764)
27. Dominguez, C., Boelens, R. and Bonvin, A. M. (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125, 1731-1737 (Pubitemid 36232568)
28. de Vries, S. J., van Dijk, A. D., Krzeminski, M., van Dijk, M., Thureau, A., Hsu, V., Wassenaar, T. and Bonvin, A. M. (2007) HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69, 726-733 (Pubitemid 350210131)
29. Vijay-Kumar, S., Bugg, C. E., Wilkinson, K. D., Vierstra, R. D., Hatfield, P. M. and Cook, W. J. (1987) Comparison of the three-dimensional structures of human, yeast, and oat ubiquitin. J. Biol. Chem. 262, 6396-6399 (Pubitemid 17103051)
30. Pettersson, S., Kelleher, M., Pion, E., Wallace, M. and Ball, K. L. (2009) Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2. Biochem. J. 418, 575-585
31. Wang, X., Wang, J. and Jiang, X. (2011) MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination. J. Biol. Chem. 286, 23725-23734
32. Escalante, C. R., Yie, J., Thanos, D. and Aggarwal, A. K. (1998) Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 391, 103-106 (Pubitemid 28079225)
33. Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W. et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591-596
34. Meier, F., Abeywardana, T., Dhall, A., Marotta, N. P., Varkey, J., Langen, R., Chatterjee, C. and Pratt, M. R. (2012) Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation. J. Am. Chem. Soc. 134, 5468-5471
35. Passmore, L. A. and Barford, D. (2004) Getting into position: the catalytic mechanisms of protein ubiquitylation. Biochem. J. 379, 513-525 (Pubitemid 38703635)
36. David, Y., Ternette, N., Edelmann, M. J., Ziv, T., Gayer, B., Sertchook, R., Dadon, Y., Kessler, B. M. and Navon, A. (2011) E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. J. Biol. Chem. 286, 44104-44115
37. Ozkan, E., Yu, H. and Deisenhofer, J. (2005) Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases. Proc. Natl. Acad. Sci. U.S.A. 102, 18890-18895 (Pubitemid 43049537)
38. Das, R., Mariano, J., Tsai, Y. C., Kalathur, R. C., Kostova, Z., Li, J., Tarasov, S. G., McFeeters, R. L., Altieri, A. S., Ji, X. et al. (2009) Allosteric activation of E2-RING finger-mediated ubiquitylation by a structurally defined specific E2-binding region of gp78. Mol. Cell 34, 674-685
39. Pruneda, J. N., Stoll, K. E., Bolton, L. J., Brzovic, P. S. and Klevit, R. E. (2011) Ubiquitin in motion: structural studies of the ubiquitin- conjugating enzyme approximately ubiquitin conjugate. Biochemistry 50, 1624-1633
40. Lipford, J. R. and Deshaies, R. J. (2003) Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nat. Cell Biol. 5, 845-850 (Pubitemid 37220683)
41. Leung, A., Geng, F., Daulny, A., Collins, G., Guzzardo, P. and Tansey, W. P. (2008) Transcriptional control and the ubiquitin-proteasome system. Ernst Schering Found. Symp. Proc., 75-97
42. Geng, F., Wenzel, S. and Tansey, W. P. (2012) Ubiquitin and proteasomes in transcription. Annu. Rev. Biochem. 81, 177-201
43. Lickwar, C. R., Mueller, F., Hanlon, S. E., McNally, J. G. and Lieb, J. D. (2012) Genome-wide protein-DNA binding dynamics suggest a molecular clutch for transcription factor function. Nature 484, 251-255